hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
table of content part ii item 5 . market for the registrant's common equity , related stockholder matters and issuer purchases of equity securities our common stock is traded on the new york stock exchange under the trading symbol 201chfc . 201d in september 2018 , our board of directors approved a $ 1 billion share repurchase program , which replaced all existing share repurchase programs , authorizing us to repurchase common stock in the open market or through privately negotiated transactions . the timing and amount of stock repurchases will depend on market conditions and corporate , regulatory and other relevant considerations . this program may be discontinued at any time by the board of directors . the following table includes repurchases made under this program during the fourth quarter of 2018 . period total number of shares purchased average price paid per share total number of shares purchased as part of publicly announced plans or programs maximum dollar value of shares that may yet be purchased under the plans or programs .

Table:
period | total number ofshares purchased | average pricepaid per share | total number ofshares purchasedas part of publicly announced plans or programs | maximum dollarvalue of sharesthat may yet bepurchased under the plans or programs
october 2018 | 1360987 | $ 66.34 | 1360987 | $ 859039458
november 2018 | 450000 | $ 61.36 | 450000 | $ 831427985
december 2018 | 912360 | $ 53.93 | 810000 | $ 787613605
total for october to december 2018 | 2723347 |  | 2620987 | 
during the quarter ended december 31 , 2018 , 102360 shares were withheld from certain executives and employees under the terms of our share-based compensation agreements to provide funds for the payment of payroll and income taxes due at vesting of restricted stock awards .
as of february 13 , 2019 , we had approximately 97419 stockholders , including beneficial owners holding shares in street name .
we intend to consider the declaration of a dividend on a quarterly basis , although there is no assurance as to future dividends since they are dependent upon future earnings , capital requirements , our financial condition and other factors. .

Question: for the quarter ended december 31 , 2018 what was the percent of shares withheld to provide funds for the payment of payroll and income taxes in december
Answer: 3.75%
Calculation: divide(102360, 2723347)
Network advertising revenue is generated primarily from the sale of television airtime for programs or advertisements. Network advertising revenue is recognized when the program or advertisement is broadcast. Revenues are reported net of agency commissions, which are calculated as a stated percentage applied to gross billings. The Network advertising contracts are generally short-term in nature.
Network distribution revenue consists of payments received from cable, satellite and other multiple video program distribution systems for their retransmission of our network content. Network distribution revenue is recognized as earned over the life of the retransmission consent contract and varies from month to month.
Variable fees are usage/sales based, calculated on the average number of subscribers, and recognized as revenue when the usage occurs. Transaction prices are based on the contract terms, with no material judgments or estimates.
Broadcast station revenue is generated primarily from the sale of television airtime in return for a fixed fee or a portion of the related ad sales recognized by the third party. In a typical broadcast station revenue agreement, the licensee of a station makes available, for a fee, airtime on its station to a party which supplies content to be broadcast during that airtime and collects revenue from advertising aired during such content.
Broadcast station revenue is recognized over the life of the contract, when the program is broadcast. The fees that we charge can be fixed or variable and the contracts that the Company enters into are generally short-term in nature. Variable fees are usage/salesbased and recognized as revenue when the subsequent usage occurs. Transaction prices are based on the contract terms, with no material judgments or estimates.
Disaggregation of Revenues The following table disaggregates the Broadcasting segment's revenue by type (in millions):
Table:
 | Years Ended December 31, | 
 | 2019 | 2018
Network advertising | $22.7 | $28.2
Broadcast station | 11.9 | 10.8
Network distribution | 4.9 | 4.8
Other | 2.3 | 1.6
Total revenue from contracts with customers | 41.8 | 45.4
Other revenue | - | -
Total Broadcasting segment revenue | $ 41.8 | $ 45.4


Question: What is the increase / (decrease) in the network advertising from 2018 to 2019?
Answer: -5.5
Calculation: 22.7 - 28.2
The provision for income taxes differed from the provision computed by applying the Federal statutory rate to income (loss) from continuing operations before taxes due to the following:
The effective income tax rate was 18.9% and (141.8)% during the years ended December 31, 2019 and December 31, 2018, respectively. The decrease in 2019 compared to statutory tax rate of 21% was primarily due to deferred tax adjustments related to foreign tax credit carryforwards and state taxes, offset by changes in the valuation allowance and excess tax benefits resulting from the exercise of non-qualified stock options.
The effective tax rate for the year ended December 31,2018 was significantly impacted by recording a substantial increase in a valuation allowance on the entire deferred tax assets.
Table:
 | Year ended December 31, | 
 | 2019 | 2018
Federal statutory tax rate | 21.0% | 21.0%
State taxes | (4.5) | 4.4
Non deductible expenses | (0.3) | (0.6)
Tax credits | 4.0 | 4.6
Expired tax credit | (1.3) | (3.9)
Deferred tax adjustment | (4.8) | —
Stock based compensation | 1.9 | 0.8
Valuation allowance | 3.2 | (167.0)
Contingent purchase revaluation | — | (1.0)
Other | (0.3) | (0.1)
 | 18.9% | (141.8)%


Question: What was the effective income tax rate during the years ended December 31, 2019 and December 31, 2018 respectively?
Answer: 18.9%, (141.8)%
Statements of cash flows additional information (in millions):
Non-cash investing and financing activities and supplemental cash flow information are as follows:
Table:
 |  | Year Ended | 
 | April 26, 2019 | April 27, 2018 | April 28, 2017
Non-cash Investing and Financing Activities: |  |  | 
Capital expenditures incurred but not paid | $ 9 | $ 24 | $ 19
Non-cash extinguishment of sale-leaseback financing obligations | $ — | $ 130 | $ 19
Supplemental Cash Flow Information: |  |  | 
Income taxes paid, net of refunds | $ 205 | $ 87 | $ 102
Interest paid | $ 53 | $ 58 | $ 44


Question: What was the non-cash extinguishment of sale-leaseback financing in 2017?
Answer: 19
VMware Stock Repurchases
VMware purchases stock from time to time in open market transactions, subject to market conditions. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including VMware’s stock price, cash requirements for operations and business combinations, corporate, legal and regulatory requirements and other market and economic conditions. VMware is not obligated to purchase any shares under its stock repurchase programs. Purchases can be discontinued at any time VMware believes additional purchases are not warranted. From time to time, VMware also purchases stock in private transactions, such as those with Dell. All shares repurchased under VMware’s stock repurchase programs are retired.
The following table summarizes stock repurchase activity, including shares purchased from Dell, during the periods presented (aggregate purchase price in millions, shares in thousands):
(1) The aggregate purchase price of repurchased shares is classified as a reduction to additional paid-in capital until the balance is reduced to zero and the excess is recorded as a reduction to retained earnings.
Table:
 |  | For the Year Ended | 
 | January 31, 2020 | February 1, 2019 | February 2, 2018
Aggregate purchase price (1) | $1,334 | $42 | $1,449
Class A common stock repurchased | 7,664 | 286 | 13,977
Weighted-average price per share | $174.02 | $148.07 | $103.66


Question: What was the Class A common stock repurchased in 2019?
Answer: 286
11. Stock Award Plan
Total recognized stock-based compensation expense is included in our consolidated statements of operations as shown in the table below. Stock-based compensation expense includes both non-cash expense related to grants of stock-based awards as well as cash expense related to the employee discount applied to purchases of our common stock under our employee stock purchase plan.
The estimated income tax benefit of stock-based compensation expense included in the provision for income taxes for the year ended December 31, 2019 is approximately $5.3 million. No stock-based compensation costs were capitalized during the years ended December 31, 2019, 2018 and 2017. The calculation of stock-based compensation expenses includes an estimate for forfeitures at the time of grant.
This estimate can be revised in subsequent periods if actual forfeitures differ from those estimates, which are based on historical trends. Total unrecognized stock-based compensation expense related to nonvested awards and options was $62.4 million as of December 31, 2019, and this expense is expected to be recognized over a weighted-average period of 2.3 years.
Table:
 |  | Year Ended December 31, | 
(In thousands) | 2019 | 2018 | 2017
Cost of revenue: |  |  | 
Software delivery, support and maintenance | $ 2,075 | $ 2,184 | $ 2,879
Client services | 4,067 | 3,997 | 4,484
Total cost of revenue | 6,142 | 6,181 | 7,363
Selling, general and administrative expenses | 27,348 | 24,213 | 23,497
Research and development | 9,200 | 8,937 | 8,605
Total stock-based compensation expense | $ 42,690 | $ 39,331 | $ 39,465


Question: What was the total unrecognized stock-based compensation expense in 2019?
Answer: $62.4 million
The Group’s measure of segment profit, adjusted EBITDA, excludes depreciation, amortisation, impairment loss, restructuring costs, loss on disposal of fixed assets, the Group’s share of results in associates and joint ventures and other income and expense. A reconciliation of adjusted EBITDA to operating profit is shown below. For a reconciliation of operating profit to profit for the financial year, see the Consolidated income statement on page 111.
Note: 1 Share of adjusted results in equity accounted associates and joint ventures excludes amortisation of acquired customer bases and brand intangible assets, restructuring costs and other costs of €0.6 billion (2018: €0.4 billion, 2017: €0.1 billion) which are included in amortisation of acquired customer base and brand intangible assets, restructuring costs and other income and expense respectively
2 See note 31 “IAS 18 basis primary statements” for further details.
Table:
 | 2019 €m | 2018 €m | 2017 €m
Adjusted EBITDA | 14,139 | 14,737 | 14,149
Depreciation, amortisation and loss on disposal of fixed assets | (9,665) | (9,910) | (10,179)
Share of adjusted results in equity accounted associates and joint ventures1 | (291) | 389 | 164
Adjusted operating profit | 4,183 | 5,216 | 4,134
Impairment losses | (3,119) | – | –
Restructuring costs | (486) | (156) | (415)
Amortisation of acquired customer based and brand intangible assets | (583) | (974) | (1,046)
Other (expense)/income | (262) | 213 | 1,052
Operating (loss)/profit (IAS 18 basis) | (267) | 4,299 | 3,725
Impact of adoption of IFRS 152 | (684) |  | 
Operating loss (IFRS 15 basis) | (951) |  | 


Question: How much is the excluded depreciation and amortisation for 2018 adjusted EBITDA?
Answer: (9,910)
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities
(a) Cisco common stock is traded on the Nasdaq Global Select Market under the symbol CSCO. Information regarding quarterly cash dividends declared on Cisco’s common stock during fiscal 2019 and 2018 may be found in Supplementary Financial Data on page 106 of this report. There were 39,216 registered shareholders as of August 30, 2019.
(b) Not applicable.
(c) Issuer purchases of equity securities (in millions, except per-share amounts):
On September 13, 2001, we announced that our Board of Directors had authorized a stock repurchase program. On February 13, 2019, our Board of Directors authorized a $15 billion increase to the stock repurchase program. As of July 27, 2019, the remaining authorized amount for stock repurchases under this program, including the additional authorization, is approximately $13.5 billion with no termination date.
For the majority of restricted stock units granted, the number of shares issued on the date the restricted stock units vest is net of shares withheld to meet applicable tax withholding requirements. Although these withheld shares are not issued or considered common stock repurchases under our stock repurchase program and therefore are not included in the preceding table, they are treated as common stock repurchases in our financial statements as they reduce the number of shares that would have been issued upon vesting (see Note 14 to the Consolidated Financial Statements).
Table:
Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
April 28, 2019 to May 25, 2019 | 42 | $54.33 | 42 | $15,700
May 26, 2019 to June 22, 2019 | 22 | $55.07 | 22 | $14,465
June 23, 2019 to July 27, 2019 | 18 | $56.46 | 18 | $13,460
Total | 82 | $54.99 | 82 | 


Question: When did the Board of Directors authorize an increase to the stock repurchase program?
Answer: On February 13, 2019, our Board of Directors authorized a $15 billion increase to the stock repurchase program.
A summary of additions and deductions related to the allowance for doubtful accounts for the years ended March 31, 2019, 2018 and 2017 follows (amounts in millions):
(1) Deductions represent uncollectible accounts written off, net of recoveries.
Table:
 | Balance at Beginning of Year | Additions Charged to Costs and Expenses | Deductions (1) | Balance at End of Year
Allowance for doubtful accounts: |  |  |  | 
Fiscal 2019 | $2.2 | $— | $(0.2) | $2.0
Fiscal 2018 | $2.1 | $0.2 | $(0.1) | $2.2
Fiscal 2017 | $2.5 | $0.2 | $(0.6) | $2.1


Question: What was the percentage change in the deductions between 2018 and 2019?
Answer: 100
Calculation: (-0.2-(-0.1))/-0.1
NOTE 9 – CONTINGENT PURCHASE PRICE
Our purchase of CareSpeak Communications contains a contingent element that will be paid only if the Company achieves certain patient engagement revenues in 2019 and 2020. The total contingent payment may be up to $3.0 million. The target patient engagement revenues were achieved in 2019 and are expected to be achieved in 2020. The calculated fair value of the contingent payment was $2,365,000 at December 31, 2018 and $3,000,000 at December 31, 2019.
Our purchase of RMDY Health, Inc. also contains a contingent element that will be paid only if the Company achieves certain revenues in 2020 and 2021 related to the RMDY business. The total contingent payment may be up to $30.0 million. The minimum payment is $1.0 million in each of the two years. The calculated fair value of the contingent payment was $3,720,000 at December 31, 2019. We determined the fair value of the Contingent Purchase Price Payable at December 31, 2019 using a Geometric-Brownian motion analysis of the expected revenue and resulting earnout payment using inputs that include the spot price, a risk free rate of return of 1.4%, a term of 2 years, and volatility of 40%. Changes in the inputs could result in a different fair value measurement.
The total fair value of contingent purchase price payable at December 31, 2019 is as follows.
Table:
 | Current | Long-Term   | Total 
CareSpeak Communications, Inc.  | $1,500,000 | $1,500,000 | $3,000,000
RMDY Health, Inc.   | - | 3,720,000 | 3,720,000
Total  | $1,500,000 | $5,220,000 | $6,720,000


Question: What is the ratio of total fair value of the contingent payment in 2018 to 2019?
Answer: 0.79
Calculation: 2,365,000/3,000,000
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (United States Dollars in thousands, except per share data and unless otherwise indicated)
Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation from, or as a substitute for, the analysis of other GAAP financial measures, such as net income. Some of the limitations of Adjusted EBITDA include:
• It does not reflect our current contractual commitments that will have an impact on future cash flows; • It does not reflect the impact of working capital requirements or capital expenditures; and • It is not a universally consistent calculation, which limits its usefulness as a comparative measure.
Management compensates for the inherent limitations associated with using the measure of Adjusted EBITDA through disclosure of such limitations, presentation of our financial statements in accordance with GAAP and reconciliation of Adjusted EBITDA to the most directly comparable GAAP measure, net income, as presented below.
(1) Includes equity-based compensation to employees and directors, as well as equity-based payments to non-employees.
(2) Includes losses recorded in the fourth quarter of 2019 associated with the financial guarantee arrangement for a Bank Partner that did not renew its loan origination agreement when it expired in November 2019. See Note 14 to the Notes to Consolidated Financial Statements included in Item 8 for additional discussion of our financial guarantee arrangements.
(3) For the year ended December 31, 2019, includes loss on remeasurement of our tax receivable agreement liability of $9.8 million and professional fees associated with our strategic alternatives review process of $1.5 million. For the year ended December 31, 2018, includes certain costs associated with our IPO, which were not deferrable against the proceeds of the IPO. Further, includes certain costs, such as legal and debt arrangement costs, related to our March 2018 term loan upsizing. For the year ended December 31, 2017, includes one-time fees paid to an affiliate of one of the members of the board of managers in conjunction with the August 2017 term loan transaction.
(4) For the year ended December 31, 2019, includes (i) legal fees associated with IPO related litigation of $2.0 million, (ii) one-time tax compliance fees related to filing the final tax return for the Former Corporate Investors associated with the Reorganization Transactions of $0.2 million, and (iii) lien filing expenses related to certain Bank Partner solar loans of $0.6 million.
Table:
 |  | Year Ended December 31, | 
 | 2019 | 2018 | 2017
Net income | $95,973 | $127,980 | $138,668
Interest expense | 23,860 | 23,584 | 7,536
Tax expense (benefit) | (7,125) | 5,534 | —
Depreciation and amortization | 7,304 | 4,478 | 3,983
Equity-based compensation expense(1) | 13,769 | 6,054 | 4,253
Change in financial guarantee liability(2) | 16,215 | — | —
Transaction expenses(3) | 11,345 | 2,393 | 2,612
Non-recurring expenses(4) | 2,804 | — | —
Adjusted EBITDA | $164,145 | $170,023 | $157,052


Question: Which years does the table show?
Answer: 2019, 2018, 2017
NOTE 5 – PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment is summarized as follows (in thousands):
We do not have leasehold improvements nor do we have capitalized leases. Costs of betterments are capitalized while maintenance costs and repair costs are charged to operations as incurred. When a depreciable asset is retired from service, the cost and accumulated depreciation will be removed from the respective accounts.
Depreciation expense was $66 thousand and $73 thousand for each of the years ended December 31, 2019 and 2018, respectively.
Table:
 | December 31, | 
 | 2019 | 2018
Building and improvements | $1,273 | $1,273
Scientific equipment | 597 | 598
Computer hardware and software | 106 | 107
Machinery and equipment | 274 | 275
Land and improvements | 162 | 162
Other personal property | 70 | 70
Office equipment | 27 | 27
 | 2,509 | 2,512
Less: accumulated depreciation | (1,969) | (1,906)
Total property, plant and equipment, net | $ 540 | $ 606


Question: What was the depreciation expense in 2018?
Answer: $73 thousand
Contractual Obligations
Following is a summary of our contractual cash obligations as of February 28, 2019 (in thousands):
Purchase obligations consist primarily of inventory purchase commitments.
Table:
 |  |  | Future Estimated Cash Payments Due by Period |  | 
 | Less than | 1 - 3 | 3 - 5 |  | 
Contractual Obligations | 1 year | years | years | > 5 years | Total
Convertible senior notes principal | $- | $122,527 | $- | $230,000 | $352,527
Convertible senior notes stated interest | 6,591 | 10,196 | 9,200 | 6,900 | 32,887
Operating leases | 7,565 | 12,628 | 12,325 | 7,659 | 40,177
Purchase obligations | 39,390 | - | - | - | 39,390
Total contractual obligations | $53,546 | $145,351 | $21,525 | $244,559 | $464,981


Question: How much do the top 3 contractual obligation terms add up to?
Answer: 432094
Calculation: (352,527+40,177+39,390)
NOTE 11 - STOCK CAPITAL (Cont.)
Share-based compensation to employees and to directors: (Cont.)
Restricted Stock:
The Company awards stock and restricted stock to certain employees, officers, directors, and/or service providers. The restricted stock vests in accordance with such conditions and restrictions determined by the GNC Committee. These conditions and restrictions may include the achievement of certain performance goals and/or continued employment with the Company through a specified restricted period. The purchase price (if any) of shares of restricted stock is determined by the GNC Committee. If the performance goals and other restrictions are not attained, the grantee will automatically forfeit their unvested awards of restricted stock to the Company. Compensation expense for restricted stock is based on fair market value at the grant date.
The total compensation expense recorded by the Company in respect of its stock and restricted stock awards to certain employees, officers, directors, and service providers for the year ended December 31, 2019 and 2018 amounted to $392 and $506, respectively.
Table:
 | Number of Restricted Stock | Weighted Average Grant Date Fair Value | Weighted Average Remaining Contractual Term (Years)
Nonvested as of December 31, 2017 | 126,808 | 4.25 | 1.31
Granted | 144,447 | 3.59 | 
Vested | 118,347 | 3.81 | 
Forfeitures | - | - | 
Nonvested as of December 31, 2018 | 152,908 | 3.96 | 1.56
Granted | 113,012 | 3.98 | 
Vested | 64,535 | 3.88 | 
Forfeitures | - | - | 
Nonvested as of December 31, 2019 | 201,385 | 4.00 | 1.95


Question: What is the percentage change in the number of noninvested restricted stock from 2018 to 2019?
Answer: 31.7
Calculation: (201,385-152,908)/152,908